Zimmer Biomet Welcomes Kristen Cardillo as New Chief Communications Officer

Zimmer Biomet Welcomes Kristen Cardillo as Chief Communications Officer

On March 6, 2025, Zimmer Biomet Holdings, Inc. announced the appointment of Kristen Cardillo as Senior Vice President and Chief Communications Officer. This strategic move is designed to bolster Zimmer Biomet's communications and engage key stakeholders within the medical technology sector. She will officially join the organization on March 10, 2025, reporting directly to President and CEO Ivan Tornos.

In her new role, Cardillo is expected to lead the company's global communication efforts, amplifying Zimmer Biomet's story within the MedTech field. Ivan Tornos expressed his optimism about Cardillo's capabilities, highlighting her history of developing impactful narratives that resonate within the corporate sphere. Tornos mentioned, "Kristen's expertise in shaping compelling corporate narratives and leading high-impact communications strategies will be invaluable as we continue driving Zimmer Biomet's bold vision forward."

Prior to joining Zimmer Biomet, Cardillo served as Vice President of Corporate Communications at 10x Genomics, a company focused on life science tools. Her previous experience also includes a significant role at Becton, Dickinson and Company (BD), where she was responsible for global communications and public relations. In this capacity, Cardillo contributed significantly to BD’s strategic initiatives, brand management, and cultural development through various communication channels.

With a strong background in corporate communications, Cardillo’s history also features positions at CareFusion and Cardinal Health, where she honed her skills in internal and external communications, making her a well-rounded addition to the Zimmer Biomet team.

Academic credentials further bolster Cardillo's profile. She holds a Bachelor of Science degree in Telecommunications from Ohio University, equipping her with the foundational skills necessary for effective media and communications management.

As Zimmer Biomet aims to continue leading innovations in the MedTech industry, the addition of Cardillo is seen as a vital step in enhancing brand engagement and supporting the overarching mission of improving the patient experience. The company possesses a comprehensive portfolio that seeks to maximize mobility and advance health through innovative products and integrated digital solutions, which leverage data and artificial intelligence for optimal results.

With over 90 years of established expertise, Zimmer Biomet is well-positioned to thrive in the dynamic landscape of medical technology. The company operates in over 25 countries and boasts sales in over 100 countries, leveraging its legacy of trusted leadership to deliver high-quality solutions to both patients and healthcare providers. Zimmer Biomet continues to foster a culture of evolution and innovation, as they strive to push the boundaries of medical technology.

For those wishing to learn more about Zimmer Biomet's offerings, operations, or to explore teamwork opportunities, further information is accessible through their official website and various social media channels. The company remains committed to transparency and engagement with its stakeholders, particularly through effective communications strategies, which Kristen Cardillo is expected to enhance significantly.

In summary, Kristen Cardillo’s appointment is not simply a filled position but a strategic maneuver aiming at reinforcing Zimmer Biomet’s status in the industry. Under her leadership, the company seeks to amplify its innovation narrative, deepen stakeholder relationships, and further solidify its reputation as a leading name in the MedTech market.